{"doi":"10.1016/j.diabres.2014.07.028","title":"Vildagliptin in patients with type 2 diabetes mellitus and renal impairment","abstract":null,"journal":"Diabetes Research and Clinical Practice","year":2014,"id":619534,"datarank":0.16479184330021646,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"self_citation_contribution":0.16479184330021646,"citation_network_contribution":0.0,"self_endowment_contribution":0.16479184330021646,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1598852,"name":"Neelesh Dongre","orcid":null,"position":1,"is_corresponding":false},{"id":1598853,"name":"Wolfgang Kothny","orcid":null,"position":2,"is_corresponding":false},{"id":1418733,"name":"Per-Henrik Groop","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Vildagliptin in patients with type 2 diabetes mellitus and renal impairment","abstract":null,"is_dataset_classified":null,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"25193334","pmcid":null,"openalex_id":"https://openalex.org/W2082751271","authors":[],"funders":[{"funder_name":"Novartis Pharma AG","grant_id":"","title":null}],"total_grants":1,"fwci":0.1992,"citation_percentile":0.55720491,"influential_citations":0,"citation_trend":[{"year":2016,"count":1},{"year":2021,"count":1}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0168822714003222?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0168822714003222?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.diabres.2014.07.028","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/25193334","host_type":"repository"}],"fields_of_study":["Diabetes Treatment and Management","Diabetes Management and Research","Pharmacology and Obesity Treatment"],"mesh_terms":["Vildagliptin","Adamantane","Blood Glucose","Creatinine","Diabetes Mellitus, Type 2","Humans","Male","Nitriles","Pyrrolidines","Renal Insufficiency","Dipeptidyl-Peptidase IV Inhibitors"],"keywords":["Vildagliptin","Saxagliptin","Alogliptin","Medicine","Linagliptin","Sitagliptin","Metformin","Type 2 Diabetes Mellitus","Diabetes mellitus","Internal medicine","Type 2 diabetes","Renal glucose reabsorption","Dipeptidyl peptidase-4","Pharmacology","Renal function","Dapagliflozin","Endocrinology","Renal impairment","Dipeptidyl Peptidase-4 Inhibitor","Anti-hyperglycaemic Agent"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-03T07:31:10.738521Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}